Observation study for Japanese patients with head and neck cancer by combination therapy with cetuximab
Phase of Trial: Phase IV
Latest Information Update: 02 Jul 2015
Price : $35 *
At a glance
- Drugs Cetuximab (Primary)
- Indications Head and neck cancer
- Focus Therapeutic Use
- 02 Jul 2015 Status changed from not yet recruiting to recruiting as per University Hospital Medical Information Network - Japan.
- 07 Apr 2014 Planned initiation date changed from 1 Oct 2013 to 12 Dec 2013 as reported by University Hospital Medical Information Network - Japan.
- 03 Oct 2013 New trial record